May 11, 2021
Business News

ACRO Releases New Report on the Past, Present, and Future of Risk-Based Monitoring

WASHINGTON–()–Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial quality. To better understand implementation across the industry, the Association of Clinical Research Organizations (ACRO) conducted a landscape survey of RBM implementation across 6,513 clinical trials that were ongoing in 2019 and compiled the information in a comprehensive report.

After an unprecedented year, the clinical research industry has proved innovative, even in difficult circumstances. ACRO’s latest report highlights a significant shift to risk-based monitoring, titled Risk-based Monitoring in Clinical Trials: Past, Present &…

Click here to view the original article.

Related Posts

You might also like ...

Tangoe Recognized as a Visionary in the 2021 Gartner Magic Quadrant for Managed Mobility Services, Global
ZoomInfo to Host Virtual Investor and Analyst Day on June 14, 2021; Executives to Participate in Upcoming Investor Conferences
AON Splash Image
Danaos Corporation Announces Implementation of Dividend Reinvestment Plan